Skip to main content

Security report for incyte.com

Incyte · Healthcare · United States

Low risk. 1 critical or high finding in SSL/TLS.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

Incyte is a well-established global biopharmaceutical company specializing in the discovery, development, and commercialization of novel medicines addressing serious unmet medical needs. The company maintains a strong market position with a comprehensive portfolio focused on hematology, oncology, inflammation, and autoimmunity. Their website reflects a mature digital presence with clear targeting of healthcare professionals, patients, investors, and partners. Technically, the site is built on Drupal CMS with modern libraries and frameworks, offering good mobile optimization and accessibility. Security posture is solid with HTTPS enforcement and domain management best practices, though there is room for improvement in publishing explicit security policies and headers. Privacy compliance is robust, featuring GDPR-aligned cookie consent mechanisms and a comprehensive privacy policy. Overall, the site demonstrates high professionalism and trustworthiness, supporting Incyte's corporate reputation.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching incyte.com

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
57
Security headers
80
Email security
60
DNS health
80
Network security
100
GDPR outside view
88
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Brand lookalikes

Add-on

Domains that imitate incyte.com and could be used for phishing or spoofed email, tracked in OffSeq Breach.

Tracked
36
Registered
36
Resolving
36
High or critical
0

Last checked 2026-07-01

Masked preview

  • in••••.comMediumbitsquatting
  • in••••.comMediumbitsquatting
  • 1n••••.comMediumhomoglyph

See the full lookalike list

A one-off add-on that lists up to 20 of the highest-risk lookalikes of incyte.com with registration, mail-server, certificate and DNS signals.

Select it in the checkout above.

Lookalike data refreshes continuously. Monitoring on Breach alerts you when a variant is registered, gains a mail server or starts serving HTTPS.

Open in Breach(opens in a new tab)Monitor on Breach(opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Incyte operates in the healthcare sector with a focus on biopharmaceutical innovation. Their business model centers on research-driven drug development and strategic partnerships. The company targets multiple customer segments including healthcare providers, patients, and investors. The presence of multiple country-specific domains indicates a global footprint. The website content and structure support investor relations and corporate transparency, enhancing competitive advantage. The company’s long domain history and consistent branding reinforce market credibility. No direct revenue streams or financial data were extracted, but investor relations content suggests a publicly traded entity with mature operations.

Security posture

The website employs HTTPS and domain registration protections such as clientTransferProhibited status, indicating good baseline security. Cookie consent is managed via OneTrust, supporting GDPR compliance. However, no explicit security policy or incident response contact information was found, which could be a gap in transparency. Security headers were not detected in the provided data, suggesting potential for enhancement. No vulnerabilities or exposed sensitive data were identified. The absence of a vulnerability disclosure policy or security.txt file limits external security engagement. Overall, the security posture is solid but could benefit from more explicit security documentation and header implementation.

Recommendations

  1. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  2. Publish a dedicated security policy page including incident response contacts to improve transparency.
  3. Implement and enforce security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  4. Consider publishing a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  5. Regularly audit third-party libraries and scripts to ensure no vulnerabilities are introduced.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Incyte
Description
Incyte is a global biopharmaceutical company focused on finding innovative solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Key services
Drug development, Pharmaceutical portfolio, Hematology and oncology treatments, Inflammation and autoimmunity treatments, Partnerships
Content quality
excellent
Branding
consistent

Technology

Stack
Drupal CMS, jQuery UI, Bootstrap, Font Awesome, Video.js, OneTrust Cookie Consent
Frameworks
Drupal
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Domain status includes clientTransferProhibited and serverUpdateProhibited
  • Cookie consent mechanism implemented

Analytics and tracking

Tracking level
minimal
Privacy practices
good

Advertising

Tracking pixels
OneTrust
Marketing tools
OneTrust Cookie Consent
Transparency
basic

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is a professional corporate site for a global biopharmaceutical company.
  2. Content is rich, well-structured, and targeted to multiple audiences including investors, healthcare professionals, and patients.
  3. Strong branding and consistent design across pages.
  4. Cookie consent and privacy policies are implemented with GDPR compliance.
  5. No visible security policy or incident response contact information found.
  6. No terms of service explicitly found.
  7. WHOIS data supports legitimacy and long-term operation.
  8. No suspicious or malicious content detected.
  9. No exposed sensitive data or vulnerable scripts detected in provided content.
Technical notes

Notes

The website is built on Drupal CMS with integration of jQuery UI, Bootstrap, Font Awesome, and Video.js, indicating a modern and modular tech stack. The use of OneTrust for cookie consent shows attention to privacy compliance. The site is mobile optimized and accessible with good SEO metadata including Open Graph and JSON-LD structured data. Hosting details are limited but domain registrar is CSC Corporate Domains, Inc., a reputable provider. Performance is moderate, likely due to rich media content. No critical technical debt or deprecated technologies were detected. Opportunities exist to improve security headers and DNS security. Overall, the technical infrastructure supports a professional corporate web presence.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with incyte.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review incyte.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.